Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 82 | 2026 | 276 | 17.450 |
Why?
|
| Knee Joint | 54 | 2026 | 170 | 7.400 |
Why?
|
| Osteoarthritis | 10 | 2024 | 103 | 3.820 |
Why?
|
| Disease Progression | 34 | 2026 | 2203 | 2.220 |
Why?
|
| Tibia | 15 | 2026 | 81 | 2.080 |
Why?
|
| Radiography | 25 | 2025 | 741 | 2.030 |
Why?
|
| Arthralgia | 9 | 2024 | 77 | 2.020 |
Why?
|
| Bone Density | 9 | 2026 | 365 | 1.860 |
Why?
|
| Running | 3 | 2018 | 32 | 1.620 |
Why?
|
| Cartilage, Articular | 13 | 2023 | 64 | 1.580 |
Why?
|
| Exercise | 7 | 2025 | 868 | 1.350 |
Why?
|
| Bone Marrow | 12 | 2020 | 316 | 1.280 |
Why?
|
| Pain | 10 | 2024 | 432 | 1.180 |
Why?
|
| Magnetic Resonance Imaging | 39 | 2026 | 3868 | 1.160 |
Why?
|
| Gardening | 2 | 2025 | 18 | 1.140 |
Why?
|
| Middle Aged | 70 | 2026 | 28510 | 1.100 |
Why?
|
| Aged | 58 | 2026 | 20968 | 1.080 |
Why?
|
| Knee Injuries | 9 | 2023 | 40 | 1.030 |
Why?
|
| Longitudinal Studies | 20 | 2023 | 1503 | 1.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 7 | 2023 | 137 | 0.980 |
Why?
|
| Cross-Sectional Studies | 18 | 2025 | 3825 | 0.970 |
Why?
|
| Synovitis | 7 | 2022 | 23 | 0.910 |
Why?
|
| Pain Measurement | 13 | 2019 | 351 | 0.890 |
Why?
|
| Bicycling | 1 | 2024 | 35 | 0.830 |
Why?
|
| Exercise Therapy | 2 | 2024 | 171 | 0.820 |
Why?
|
| Weight-Bearing | 7 | 2016 | 43 | 0.820 |
Why?
|
| Walking | 5 | 2022 | 215 | 0.820 |
Why?
|
| Resistance Training | 1 | 2023 | 26 | 0.810 |
Why?
|
| Menisci, Tibial | 7 | 2023 | 41 | 0.800 |
Why?
|
| Cancellous Bone | 2 | 2026 | 11 | 0.790 |
Why?
|
| Femur | 7 | 2026 | 78 | 0.790 |
Why?
|
| Humans | 100 | 2026 | 130842 | 0.760 |
Why?
|
| Bone Malalignment | 3 | 2026 | 5 | 0.750 |
Why?
|
| Male | 73 | 2026 | 64715 | 0.740 |
Why?
|
| Methotrexate | 1 | 2024 | 337 | 0.730 |
Why?
|
| Female | 75 | 2026 | 70670 | 0.680 |
Why?
|
| Swimming | 1 | 2019 | 29 | 0.620 |
Why?
|
| Football | 1 | 2020 | 36 | 0.620 |
Why?
|
| Tibial Meniscus Injuries | 4 | 2019 | 35 | 0.580 |
Why?
|
| Chronic Pain | 1 | 2021 | 160 | 0.570 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 3062 | 0.550 |
Why?
|
| Physicians | 1 | 2024 | 637 | 0.520 |
Why?
|
| Absorptiometry, Photon | 7 | 2026 | 198 | 0.520 |
Why?
|
| Logistic Models | 10 | 2025 | 1825 | 0.490 |
Why?
|
| Knee | 2 | 2015 | 21 | 0.490 |
Why?
|
| Osteoarthritis, Hip | 3 | 2023 | 62 | 0.470 |
Why?
|
| Risk Factors | 23 | 2023 | 11004 | 0.450 |
Why?
|
| Motor Activity | 2 | 2015 | 500 | 0.450 |
Why?
|
| Bone Marrow Diseases | 3 | 2011 | 45 | 0.440 |
Why?
|
| Quality of Life | 1 | 2024 | 2089 | 0.430 |
Why?
|
| Hand Joints | 2 | 2024 | 6 | 0.400 |
Why?
|
| Pain Management | 3 | 2019 | 197 | 0.370 |
Why?
|
| Body Mass Index | 11 | 2020 | 1685 | 0.360 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2025 | 224 | 0.360 |
Why?
|
| Blood Pressure | 1 | 2017 | 1342 | 0.350 |
Why?
|
| Cartilage Diseases | 2 | 2022 | 17 | 0.340 |
Why?
|
| Analgesics | 2 | 2009 | 121 | 0.330 |
Why?
|
| Joint Instability | 2 | 2019 | 55 | 0.290 |
Why?
|
| Hypertension | 1 | 2017 | 1356 | 0.280 |
Why?
|
| Prospective Studies | 6 | 2023 | 6494 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2025 | 17681 | 0.280 |
Why?
|
| Prevalence | 3 | 2025 | 2685 | 0.270 |
Why?
|
| Cohort Studies | 7 | 2024 | 5091 | 0.270 |
Why?
|
| Osteophyte | 2 | 2026 | 8 | 0.270 |
Why?
|
| United States | 10 | 2025 | 11839 | 0.270 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 4040 | 0.260 |
Why?
|
| Time Factors | 10 | 2019 | 6243 | 0.250 |
Why?
|
| Symptom Assessment | 2 | 2018 | 111 | 0.250 |
Why?
|
| Vasculitis | 1 | 2006 | 46 | 0.250 |
Why?
|
| Biomechanical Phenomena | 3 | 2017 | 262 | 0.230 |
Why?
|
| Incidence | 6 | 2022 | 3350 | 0.230 |
Why?
|
| Life Style | 1 | 2008 | 447 | 0.230 |
Why?
|
| Patient Education as Topic | 2 | 2024 | 459 | 0.220 |
Why?
|
| Denmark | 1 | 2024 | 28 | 0.220 |
Why?
|
| Case-Control Studies | 10 | 2023 | 3418 | 0.220 |
Why?
|
| Prognosis | 7 | 2023 | 4934 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2025 | 260 | 0.210 |
Why?
|
| Papillomavirus Vaccines | 1 | 2025 | 111 | 0.210 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 252 | 0.210 |
Why?
|
| Clinical Clerkship | 1 | 2024 | 72 | 0.210 |
Why?
|
| Skin | 1 | 2006 | 547 | 0.200 |
Why?
|
| Radiology | 1 | 2024 | 125 | 0.190 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 108 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2019 | 3717 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2024 | 119 | 0.190 |
Why?
|
| Walking Speed | 2 | 2020 | 18 | 0.190 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 418 | 0.180 |
Why?
|
| Adult | 10 | 2025 | 31274 | 0.170 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2019 | 10 | 0.170 |
Why?
|
| Linear Models | 3 | 2018 | 692 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2024 | 468 | 0.170 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 384 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.160 |
Why?
|
| Vaccination | 1 | 2025 | 1034 | 0.160 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2021 | 101 | 0.150 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2019 | 1 | 0.150 |
Why?
|
| Ligaments, Articular | 1 | 2019 | 21 | 0.150 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 5230 | 0.150 |
Why?
|
| Synovial Membrane | 1 | 2019 | 27 | 0.150 |
Why?
|
| Curriculum | 1 | 2024 | 789 | 0.150 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 2935 | 0.140 |
Why?
|
| Rheumatology | 1 | 2020 | 128 | 0.140 |
Why?
|
| Arthrography | 1 | 2018 | 6 | 0.140 |
Why?
|
| X-Rays | 1 | 2018 | 30 | 0.140 |
Why?
|
| Sound | 1 | 2017 | 19 | 0.140 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2017 | 5 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2019 | 363 | 0.130 |
Why?
|
| Systole | 1 | 2017 | 196 | 0.130 |
Why?
|
| Meniscus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Homeostasis | 2 | 2018 | 715 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 219 | 0.120 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 16 | 0.120 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2007 | 39 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 472 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2019 | 496 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 17 | 0.120 |
Why?
|
| Mammography | 1 | 2016 | 129 | 0.110 |
Why?
|
| Venous Thrombosis | 2 | 2007 | 169 | 0.110 |
Why?
|
| Vitamin D | 2 | 2014 | 196 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 421 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2020 | 1231 | 0.100 |
Why?
|
| Age Factors | 5 | 2020 | 2849 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 85 | 0.100 |
Why?
|
| Glucose | 1 | 2018 | 848 | 0.100 |
Why?
|
| Young Adult | 3 | 2025 | 10025 | 0.100 |
Why?
|
| Cartilage | 1 | 2013 | 52 | 0.100 |
Why?
|
| Hand | 2 | 2024 | 95 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 379 | 0.090 |
Why?
|
| Disability Evaluation | 2 | 2015 | 191 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2017 | 1107 | 0.090 |
Why?
|
| Vitamins | 1 | 2013 | 114 | 0.090 |
Why?
|
| Phenotype | 1 | 2022 | 4483 | 0.090 |
Why?
|
| Body Weight | 1 | 2016 | 989 | 0.090 |
Why?
|
| Hyaline Cartilage | 1 | 2011 | 2 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2021 | 12912 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2011 | 28 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1679 | 0.080 |
Why?
|
| Orthotic Devices | 1 | 2009 | 20 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 906 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 47 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 45 | 0.070 |
Why?
|
| Weight Loss | 1 | 2012 | 526 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 76 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2007 | 41 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1247 | 0.060 |
Why?
|
| Cefazolin | 1 | 2006 | 18 | 0.060 |
Why?
|
| Arterioles | 1 | 2006 | 38 | 0.060 |
Why?
|
| Delphi Technique | 2 | 2023 | 266 | 0.060 |
Why?
|
| Osteosclerosis | 1 | 2006 | 11 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 188 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 643 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1236 | 0.050 |
Why?
|
| Self Report | 2 | 2020 | 556 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 34 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2008 | 1232 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2016 | 80 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2024 | 124 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2648 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 223 | 0.050 |
Why?
|
| Teaching | 1 | 2024 | 199 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 281 | 0.050 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2022 | 8 | 0.050 |
Why?
|
| Counseling | 1 | 2024 | 237 | 0.050 |
Why?
|
| Observer Variation | 2 | 2014 | 317 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 1300 | 0.040 |
Why?
|
| Diet | 1 | 2008 | 1116 | 0.040 |
Why?
|
| Androstenes | 1 | 2021 | 8 | 0.040 |
Why?
|
| Phenylthiohydantoin | 1 | 2021 | 14 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 20835 | 0.040 |
Why?
|
| Taxoids | 1 | 2021 | 71 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2022 | 183 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 109 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 125 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 241 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 528 | 0.040 |
Why?
|
| Nitriles | 1 | 2021 | 162 | 0.040 |
Why?
|
| London | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1462 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2390 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2307 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2024 | 559 | 0.040 |
Why?
|
| Gait | 1 | 2020 | 133 | 0.040 |
Why?
|
| Child | 1 | 2019 | 26219 | 0.040 |
Why?
|
| Accelerometry | 1 | 2019 | 66 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1131 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 680 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 736 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 423 | 0.030 |
Why?
|
| Exercise Test | 1 | 2019 | 241 | 0.030 |
Why?
|
| Fatigue | 1 | 2019 | 195 | 0.030 |
Why?
|
| Health Personnel | 1 | 2023 | 547 | 0.030 |
Why?
|
| Hong Kong | 1 | 2016 | 21 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1625 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 453 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 188 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6784 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 617 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2553 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 84 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2127 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 366 | 0.030 |
Why?
|
| Cadaver | 1 | 2014 | 119 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1325 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 427 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 240 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 1009 | 0.020 |
Why?
|
| Ligaments | 1 | 2011 | 19 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 828 | 0.020 |
Why?
|
| Tendons | 1 | 2011 | 32 | 0.020 |
Why?
|
| Wrist Joint | 1 | 2011 | 27 | 0.020 |
Why?
|
| Boston | 1 | 2011 | 118 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1491 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1327 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 567 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 768 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 453 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 1224 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 1792 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2104 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3417 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 6150 | 0.010 |
Why?
|